|Application:||Gene expression microarray analysis|
|Number of samples:||140|
|Release date:||Aug 21 2018|
|Last update date:||Aug 21 2018|
|Dataset link||Molecular predictors of prevention of recurrence in hepatocellular carcinoma with sorafenib as adjuvant treatment in the phase 3 STORM trial|
Formalin-fixed paraffin-embedded (FFPE) tissue blocks from 140 HCC patients resected between 2008 and 2010 and randomized into treatment in the STORM clinical trial (NCT00692770) were collected from the highest enrolling centers after ad-hoc IRB clearance.There are a total of 67 samples treated with Sorafenib (Sor) and 73 are Placebo(Plac).